KOSS Koss Corp

Price (delayed)

$2.38

Market cap

$22.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.12

Enterprise value

$19.5M

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data ...

Highlights
The quick ratio has surged by 125% year-on-year but it has declined by 41% since the previous quarter
Koss's EPS has plunged by 111% YoY but it has increased by 43% from the previous quarter
Koss's gross profit has decreased by 27% YoY
KOSS's revenue is down by 15% year-on-year

Key stats

What are the main financial stats of KOSS
Market
Shares outstanding
9.25M
Market cap
$22.03M
Enterprise value
$19.5M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.7
Price to sales (P/S)
1.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.48
Earnings
Revenue
$13.21M
EBIT
-$1.2M
EBITDA
-$1M
Free cash flow
-$597,662
Per share
EPS
-$0.12
Free cash flow per share
-$0.06
Book value per share
$3.4
Revenue per share
$1.43
TBVPS
$4.11
Balance sheet
Total assets
$38M
Total liabilities
$6.6M
Debt
$0
Equity
$31.4M
Working capital
$20.84M
Liquidity
Debt to equity
0
Current ratio
12.86
Quick ratio
9.17
Net debt/EBITDA
2.52
Margins
EBITDA margin
-7.6%
Gross margin
32.7%
Net margin
-7.7%
Operating margin
-15.2%
Efficiency
Return on assets
-2.7%
Return on equity
-3.2%
Return on invested capital
-3.5%
Return on capital employed
-3.3%
Return on sales
-9.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KOSS stock price

How has the Koss stock price performed over time
Intraday
2.15%
1 week
-2.06%
1 month
-4.8%
1 year
-41.95%
YTD
-28.96%
QTD
-7.39%

Financial performance

How have Koss's revenue and profit performed over time
Revenue
$13.21M
Gross profit
$4.32M
Operating income
-$2.01M
Net income
-$1.02M
Gross margin
32.7%
Net margin
-7.7%
Koss's net margin has shrunk by 113% YoY but it has increased by 47% QoQ
Koss's net income has plunged by 111% YoY but it has increased by 46% from the previous quarter
The operating income has soared by 91% YoY and by 30% from the previous quarter
KOSS's operating margin has surged by 90% year-on-year and by 31% since the previous quarter

Growth

What is Koss's growth rate over time

Valuation

What is Koss stock price valuation
P/E
N/A
P/B
0.7
P/S
1.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.48
Koss's EPS has plunged by 111% YoY but it has increased by 43% from the previous quarter
KOSS's P/B is 74% below its 5-year quarterly average of 2.7 and 36% below its last 4 quarters average of 1.1
The stock's P/S is 49% below its 5-year quarterly average of 3.3 and 33% below its last 4 quarters average of 2.5
KOSS's revenue is down by 15% year-on-year

Efficiency

How efficient is Koss business performance
Koss's ROS has plunged by 114% YoY but it has increased by 45% from the previous quarter
Koss's ROA has plunged by 110% YoY but it has increased by 45% from the previous quarter
The company's return on equity has shrunk by 109% YoY but it rose by 47% QoQ
KOSS's ROIC has shrunk by 107% YoY but it is up by 46% QoQ

Dividends

What is KOSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KOSS.

Financial health

How did Koss financials performed over time
The quick ratio has surged by 125% year-on-year but it has declined by 41% since the previous quarter
The current ratio has soared by 80% YoY but it has contracted by 37% from the previous quarter
Koss's debt is 100% lower than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.